This ontology capability provides the foundational structure for managing electronic records and signatures in compliance with FDA 21 CFR Part 11. It ensures that pharmaceutical data remains authentic, trustworthy, and legally admissible throughout its lifecycle. By enforcing strict audit trails and access controls, the system supports organizations in meeting rigorous regulatory standards without introducing unrelated data governance features. The focus remains exclusively on the technical requirements for electronic records integrity.
The core functionality enforces validation rules that prevent unauthorized modifications to critical pharmaceutical data, ensuring every record meets Part 11 criteria.
Automated audit trail generation captures user actions with timestamps and IP addresses, providing a verifiable history of all system interactions.
Role-based access controls restrict data entry and review permissions based on the specific responsibilities defined for each compliance officer.
Electronic signature validation ensures only authorized personnel can approve or reject records, maintaining the integrity of the submission process.
System integrity checks continuously monitor for tampering attempts, alerting administrators immediately upon detecting suspicious activity patterns.
Data retention policies automatically archive compliant records for the required duration, ensuring long-term availability for regulatory review.
Percentage of records with valid electronic signatures
Audit trail completeness rate
Time to detect unauthorized access attempts
Verifies identity and authorization before allowing record modification.
Logs all user actions with immutable timestamps and IP data.
Enforces strict permission levels based on defined job responsibilities.
Manages archival processes to meet specific regulatory holding periods.
Seamlessly integrates with existing laboratory information management systems to streamline data entry workflows.
Provides real-time dashboards for compliance officers to monitor adherence to Part 11 standards across multiple sites.
Generates standardized reports that align directly with FDA inspection requirements and audit expectations.
Directly addresses FDA Part 11 requirements for electronic records without requiring external mapping tools.
Minimizes the risk of non-compliance penalties by enforcing strict controls at the data entry point.
Reduces manual verification time through automated validation and structured record templates.
Module Snapshot
Handles user authentication and role assignment to ensure only authorized personnel interact with electronic records.
Applies cryptographic hashing and validation rules to prevent unauthorized changes to submitted data.
Captures and stores detailed transaction histories for full traceability of all system activities.